Thaum tus tswv tsev sab laj nrog lawv tus kws kho tsiaj txog kev tiv thaiv kab mob parasite, kev sib tham feem ntau los rau ib lo lus nug: vim li cas siv ob yam khoom thaum ib tus tuaj yeem ua haujlwm ntawm ob qho tib si? Lo lus nug no yog lub hauv paus ntawm dab tsi uaafoxolaner thiab milbemycin oxime chewable ntsiav tshuajthiaj li tshwj xeeb hauv veterinary tshuaj. Qhov kev tsim no tsis yog tsom rau ib chav kawm kab mob cab tab sis nws hais txog kev hem thawj sab hauv thiab sab nraud los ntawm ob hom tshuaj sib cais ntawm kev ua. Kev nkag siab tias qhov no ua haujlwm li cas - thiab yog vim li cas nws thiaj li ua rau muaj qhov sib txawv - pab cov neeg yuav khoom, cov neeg muag khoom thiab cov kws kho tsiaj ua kev txiav txim siab zoo dua.

Afoxolaner Thiab Milbemycin Oxime Chewable Tablets
1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
(2) Tablet
9.375+1.875mg: 2-3.5 kg
18.75+3.75mg: 3.5-7.5kg
37.5+7.5mg:>7.5-15kg
75+15mg:>15-30kg
150+30mg: 30-60kg
(3) Ointment
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Internal Code: BM-2-117
Lub khw tseem ceeb: Tebchaws Asmeskas, Australia, Brazil, Nyiv, Lub Tebchaws Yelemees, Indonesia, UK, New Zealand, Canada thiab lwm yam.
Chaw tsim tshuaj paus: BLOOM TECH Xi'an Hoobkas
Yuav Ua Li Cas Afoxolaner thiab Milbemycin Oxime Chewable Tablets Ua Haujlwm hauv dev?
Lub Hauv Paus Kev Tshawb Fawb Tom Qab Cov Qauv
Afoxolaner thiab milbemycin oxime chewable ntsiav tshuaj muab kev tiv thaiv nrog kev sib xyaw ntawm 2 cov tshuaj sib txawv ntawm cov tshuaj nquag hauv ib lub hlis ib zaug. Afoxolaner yog ib qho tshuaj tua kab isoxazoline thiab acaricide. Milbemycin oxime yog macrocylic lactone anthelmintic uas yog tsim los ntawm fermentation ntawm Streptomyces hygroscopicus. "Txhua yam khoom muaj lub hom phiaj sib txawv ntawm kev lom neeg, yog li cov qauv tsis nyob ntawm ib qho chaw tsis muaj zog hauv cov kab mob physiology."
Kev tsim cov laj thawj yog txhawb los ntawm cov ntaub ntawv pharmacokinetic. Tom qab kev kho qhov ncauj afoxolaner ua tiav cov ntshav ntshav siab tshaj plaws nyob rau hauv 2 mus rau 4 teev nrog ib nrab-lub neej ntawm kwv yees li ob lub lis piam, muab kev tiv thaiv cov kab mob sab nraud nyob rau lub hli noj.


Qhov siab tshaj plaws ntawm milbemycin oxime Cheebtsam A3 thiab A4 tau pom nyob nruab nrab ntawm 1 thiab 2 teev nrog ib nrab-lub neej ntawm 1.6 hnub thiab 3.3 hnub, feem. Ob yam khoom yog absorbed sai heev kom koj tau txais kev tiv thaiv thaum ntxov thiab tas li.
Yuav ua li cas tom qab ib tug dev noj ntsiav tshuaj
Kev faib tawm ntawm afoxolaner hauv cov ntaub so ntswg tom qab nqus yog 2.6 ± 0.6 L / kg. Nws qhov tseeb ntawm qhov ncauj bioavailability yog 88% qhia tias lub cev siv feem ntau ntawm qhov nws tau muab. Lub bioavailability ntawm milbemycin oxime A3 thiab A4 yog 81 thiab 65%, feem. Ob qho tshuaj yog metabolized feem ntau hauv daim siab thiab tawm hauv cov quav thiab zis. Qhov kev tshem tawm ob txoj kev no txo qis kev tsim kho raws li kev noj tshuaj txhua hli hauv cov dev laus noj qab haus huv.
Afoxolaner thiab Milbemycin Oxime Chewable Tablets: Ob Cov Khoom Ua Si, Cov Hom Phiaj Sib txawv
Afoxolaner thiab Nws Lub Luag Haujlwm Tawm Tsam Sab Nraud Parasites
Afoxolaner inhibits gamma-aminobutyric acid (GABA)-gated chloride ion raws ntawm arthropods. Cov kab no raug kaw kom cov chloride ions tsis tuaj yeem hla ib txwm hla cov kab mob ntawm cov paj hlwb. Qhov no ua rau muaj kev tsim tawm ntawm lub hlwb, ua rau hyperexcitation, tswj tsis tau cov leeg nqaij, tuag tes tuag taw, thiab tuag hauv cov kab mob hauv lub hom phiaj - feem ntau yog dev mub, zuam thiab mites. Qhov tseem ceeb, afoxolaner muaj ntau dua affinity rau GABA receptors ntawm arthropods dua rau cov tsiaj txhu receptors, uas muab ib tug loj kev nyab xeeb margin rau dev.
Hniav thiab zuam yuav tsum tau kov los yog nqos cov khoom los ntawm tus dev cov ntshav kom raug cuam tshuam.


Cov kev tshawb fawb qhia tias kev tua cov dev mub pib nyob rau hauv ib teev tom qab muab cov ntsiav tshuaj thiab tua cov zuam tshwm sim ntawm 24 mus rau 48 teev, nyob ntawm seb hom.
Milbemycin Oxime thiab nws lub luag haujlwm tawm tsam Internal Parasites
Milbemycin oxime muaj qhov sib txawv kiag li ntawm kev ua. Nws ua rau glutamate gated chloride channels ntawm invertebrate neuron thiab cov leeg hlwb. Qhov no ua rau muaj kev nce hauv daim nyias nyias permeability thiab hyperpolarization. Qhov kev tiv thaiv hluav taws xob tsis txaus no ua rau tuag tes tuag taw thiab tuag ntawm cov kab mob hauv lub cev xws li kab mob plawv (Dirofilaria immitis), plab hnyuv nematodes (Toxocara canis thiab Ancylostoma caninum), thiab cov kab mob whipworms (Trichuris vulpis), uas ua rau.afoxolaner thiab milbemycin oxime chewable ntsiav tshuajmuaj feem xyuam rau broad-spectrum parasite tswj.
Milbemycin oxime muaj qhov txwv tsis pub muaj kev cuam tshuam rau cov tsiaj txhu hauv cov ntshav-hlwb hauv cov hlab ntsha hauv lub cev thiab cov kab mob hauv nruab nrab ntawm lub paj hlwb tsuas muaj ob peb txoj hauv kev tsis sib xws ntawm glutamate-gated chloride. Lub siab tolerability profile ntawm cov tshuaj nyob rau hauv feem ntau ntawm cov breeds yog piav qhia los ntawm no metabolic sib txawv ntawm tus tswv tsev thiab parasite phiaj.
Yuav ua li cas Afoxolaner thiab Milbemycin Oxime Chewable Tablets Ua ke Sab Nraud thiab Internal Parasite Control
Synchronized Kev Pabcuam Los ntawm Kev Siv Ib Leeg
Afoxolaner thiab Milbemycin Oxime muaj nyob rau hauv cov ntsiav tshuaj chewable, muab ob txoj kev sib txawv ntawm kev ua hauv ib lub ntsiav tshuaj txaus siab. Hauv thaj chaw muaj kev pheej hmoo siab tus dev yog muaj kev pheej hmoo tam sim ntawm fleas ticks heartworm vector yoov tshaj cum thiab cov av yug hauv plab hnyuv nematodes Kev siv ntau lub sijhawm sib txawv rau cov teeb meem no tsim qhov sib txawv hauv kev pab them nqi thiab nce qhov tshwm sim ntawm cov tshuaj uas ploj lawm.
Daim ntawv qhia no tshem tawm cov teeb meem kev ua raws cai, raws li afoxolaner thiab milbemycin oxime tau ua ke hauv ib qho kev tswj hwm txhua hli. Veterinary ua raws li cov ntaub ntawv qhia tau hais tias dev ntawm cov khoom tsawg dua muaj kev ua raws li cov kev tswj hwm kab mob parasite.


Qhov kev xaiv architectural no coj ncaj qha mus rau cov kab mob parasite tswj tau zoo dua ntawm cov pej xeem.
Kev Pab Cuam Tshaj Plaws Hauv Cov Kab Mob Kab Mob
Tag nrho cov dej num sib txawv ntawm kev kho mob ntau yam. Nws kuj tseem siv tau rau cov kab mob mange thiab fleas (Ctenocephalides felis thiab C. canis) thiab ntau yam zuam nrog rau cov Ixodes, Rhipicephalus thiab Amblyomma thiab Dermacentor genera. Rau kev kho mob thiab tswj cov kab mob loj hauv plab hnyuv loj, cov kab mob hookworms thiab whipworms thaum muab rau hauv, thiab rau kev tiv thaiv kab mob plawv. Qhov no yog qhov ntau yam uas cov kws kho tsiaj tau pom nyob rau hauv kev xyaum txhua hnub hauv thaj chaw sib txawv.
Dual Mechanism ntawm Afoxolaner thiab Milbemycin Oxime Chewable Tablets
Ob Txoj Kev, Ib Lub Hom Phiaj
Cov txheej txheem dual siv tau yam tsis muaj kev cuam tshuam pharmacological ntawm ob qho tshuaj. Afoxolaner tsis ua rau glutamate-gated chloride raws thiab milbemycin oxime tsis ua rau GABA-gated txoj kev. Ob qho tshuaj muaj qhov sib txawv receptor profiles thiab yog li tsis ua rau tib lub hom phiaj lom neeg, tab sis nyob rau hauv parallel. Qhov kev tsim orthogonal no txhais tau hais tias ib feem tsis cuam tshuam rau qhov ua tau zoo ntawm lwm qhov.
Lub hom phiaj sib luag no yog qhov tseem ceeb hauv kev tswj hwm kev tawm tsam. Parasites uas txhim kho cov tshuaj tiv thaiv isoxazoline los ntawm kev hloov pauv hauv GABA receptor yog txawm li cas los xij rhiab rau glutamate-channel mechanism ntawm milbemycin oxime thiab vise versa.


Cov hom kev sib xyaw ua ke tseem yog qhov dav dav dua li cov tshuaj ib leeg, txawm hais tias kev sib kis yog qhov kev txhawj xeeb ntawm cov neeg ntawm macrolides-resistant nematodes.
Kev Nyab Xeeb Kev Nyab Xeeb Hauv Cov Qauv
Kev xaiv ntawm txhua yam rau invertebrate vs vertebrate receptor subtypes . Lub tolerability profile pom nyob rau hauv kev soj ntsuam kuaj yog vim qhov zoo xaiv ntawm afoxolaner rau GABA receptors ntawm arthropods thiab tsis tshua muaj kev nkag mus ntawm milbemycin oxime los ntawm cov tib neeg cov ntshav hlwb teeb meem. Kev ceeb toom hauv Collies thiab cov neeg yug me nyuam nrog MDR1 (ABCB1) kev hloov pauv noob, cuam tshuam nrog qis P-glycoprotein kev ua haujlwm thiab tej zaum ua rau muaj kev cuam tshuam ntau ntxiv rau milbemycin oxime hauv paj hlwb. Cov tsiaj no yuav tsum nyob rau hauv kev saib xyuas veterinary.
Vim li cas Afoxolaner thiab Milbemycin Oxime Chewable Tablets tsim los rau Broad-Spectrum Parasite Control?
Epidemiological Rationale
Kev sib koom ua ke los ntawm cov kab mob parasites yog dav, tsis tshua muaj. Kev tshawb fawb txog kab mob sib kis ntawm ntau lub teb chaws qhia cov dev ib txhij harbored los ntawm fleas, plab hnyuv nematodes thiab txaus ntshai ntawm kab mob plawv. Ib tug dav ntau yam khoom xws liafoxolaner thiab milbemycin oxime chewable ntsiav tshuajyog nyob rau hauv txoj kab nrog lub tswv yim tshuaj uas parasites tsis ntaus koj ib zaug. Qhov tseeb yog tias cov qauv tsim tau siv rau hauv ntau qhov kev nyab xeeb thiab kev nyab xeeb, los ntawm cov chaw kub thiab txias-kwv yees mus rau thaj chaw sov nrog cov zuam siab.
Specifications Ua nyob ib ncig ntawm lub ntiaj teb tiag-Lub Ntiaj Teb Dog Nyhav


This weight-based dosing range covers dogs of 2kg to >50kg nyob rau hauv tsib lub specification tiers thiab ua piv txwv cov tswv yim variability ntawm cov phooj ywg tsiaj cov pej xeem.Qhov tsib ua ke sib txawv ntawm 9.375 mg + 1.875 mg ntawm qhov qis kawg mus rau 150 mg + 30 mg rau cov tsiaj loj thiab yog li koob tshuaj nyob twj ywm nyob rau hauv lub tsim kho qhov rais ntawm 2.5 mus rau 6.9 kgner mg / kg. milbemycin oxime. Kev tsim kho theem muaj qhov ua tau zoo ib yam tsis muaj tshuaj lom neeg ntau dhau.
Lub hli Dosing raws li kev tiv thaiv ib puag ncig
Qhov koob tshuaj txhua hli ua raws tib lub sijhawm raws li kev tiv thaiv kab mob plawv pom zoo los ntawm cov koom haum kws kho tsiaj hauv ntiaj teb. Kev tiv thaiv kab mob plawv yog ua raws li kev tiv thaiv txuas ntxiv ntawm Dirofilaria immitis L3 thiab L4 larvae hauv lub sijhawm ua ntej.
Qhov kev xav tau no tau ntsib los ntawm kev txhaj tshuaj txhua hli ntawm milbemycin oxime. Ib qho kev tiv thaiv kev sib koom ua ke tau ua tiav thaum tswj fleas thiab zuam yog synchronized ntawm tib lub sijhawm txhua hli; qhov no ua kom yooj yim cov ntaub ntawv khaws cia rau tus kws kho tsiaj thiab tus tswv tus dev.
Xaus
Afoxolaner thiab milbemycin oxime chewable ntsiav tshuajtsim kom muaj kev sib xyaw ua ke zoo ntawm ob txoj kev tshuaj tshuaj sib cais hauv ib qho, noj qhov ncauj txhua hli. Afoxolaner tshem tawm cov kab mob exogenous ntawm GABA-channel inhibition. Milbemycin oxime tua cov kab mob sab hauv los ntawm kev ua kom cov glutamate-channels. Ua ke, lawv npog tag nrho cov kab mob ntawm cov kab mob uas muaj kab mob loj tshaj plaws uas tsis muaj kev cuam tshuam rau kev nyab xeeb profile uas cov kws kho tsiaj thiab cov tswv tsiaj tau tuaj txog. Cov qauv tsim qauv tsim - cov txheej txheem sib luag, cov tshuaj pharmacokinetics synchronized, qhov hnyav-calibrated dosing - ua rau nws muaj kev xaiv zoo rau kev tswj cov kab mob dav dav hauv cov dev.
Cov lus nug nquag
Q1: Puas muaj afoxolaner thiab milbemycin oxime chewable ntsiav tshuaj rau menyuam dev?
+
-
Tsis txhob siv cov dev tsawg dua 2 kg lossis tsawg dua 8 lub lis piam. Cov menyuam dev ua tau raws li lub hnub nyoog thiab qhov hnyav yuav raug muab tshuaj raws li lawv lub cev hnyav nyob rau hauv cov txheej txheem tsim nyog. Tus kws kho tsiaj yuav tsum xyuas seb cov tshuaj puas tsim nyog rau cov tsiaj me ua ntej nws pib.
Q2: Yuav ua li cas sai sai afoxolaner thiab milbemycin oxime chewable ntsiav tshuaj pib ua haujlwm tom qab tswj hwm?
+
-
Qhov siab tshaj plaws plasma concentration ntawm afoxolaner tau mus txog li ntawm 2 mus rau 4 teev tom qab noj qhov ncauj. Milbemycin oxime ncov qhov tseem ceeb tshwm sim ntawm 1 mus rau 2 teev. Cov kev ua ntawm flea feem ntau pib poob qis hauv cov sij hawm ntawm kev kho. Ticks feem ntau ploj hauv 24 mus rau 48 teev, nyob ntawm seb hom. Qib ntawm milbemycin oxime yuav tsum tau khaws cia thoob plaws lub hlis kho mob rau kev tiv thaiv kab mob plawv.
Q3: Puas muaj cov tsiaj txhu uas xav tau kev saib xyuas tshwj xeeb thaum siv cov khoom no?
+
-
Collies thiab lwm yam tsiaj uas nqa MDR1 (ABCB1) gene mutation muaj qhov tsis xws luag hauv P-glycoprotein kev ua haujlwm uas tuaj yeem ua rau nce qib ntawm milbemycin oxime hauv nruab nrab lub paj hlwb. Veterinarians yuav tsum tshuaj xyuas cov tsiaj no los txiav txim seb puas muaj kev hloov tshuaj lossis hloov khoom siv. Cov dev cev xeeb tub thiab lactating dev yuav tsum tau soj ntsuam tus kheej ua ntej kev tswj hwm.
Tau qhov twg los koj cov khoom siv los ntawm Trusted Afoxolaner thiab Milbemycin Oxime Chewable Tablets Supplier - Bloomtechz
Bloomtechz thim rov qab txhua pawg nrog kev kuaj xyuas triple-link zoo: kev soj ntsuam ntawm Hoobkas theem, kev tshuaj xyuas hauv tsev QA / QC, thiab kev kuaj thib peb. Peb cov chaw tsim khoom muaj GMP daim ntawv pov thawj, US-FDA, EU, JP thiab CFDA daim ntawv pov thawj. Bloomtechz yog tus tsim nyog muab khoom ntawmafoxolaner thiab milbemycin oxime chewable ntsiav tshuaj, muab rau 24 tus neeg koom tes thoob ntiaj teb hauv kev lag luam tshuaj, kws kho tsiaj thiab tshwj xeeb tshuaj. Peb muab API hmoov, ua tiav cov ntsiav tshuaj hauv tag nrho 5 qhov hnyav sib txawv thiab OEM / ODM customization. Yog tias koj xav pom qhov piv txwv kev ntsuam xyuas lossis xav muab qhov kev txiav txim loj, peb pab neeg tuaj yeem muab cov hnub coj ncaj ncees rau koj, pob tshab tus nqi thiab cov ntaub ntawv tag nrho rau kev lis kev cai clearance. Tiv tauj peb tam sim ntawmSales@bloomtechz.comkom tau txais tej yam pib.
Cov ntaub ntawv
1. Beugnet, F., & Franc, M. (2012). Cov tshuaj tua kab thiab acaricide molecules thiab / lossis kev sib xyaw ua ke los tiv thaiv tsiaj txhu los ntawm ectoparasites. Trends in Parasitology, 28(7), 267–279.
2. Bowman, DD, & Atkins, CE (2009). Heartworm biology, kho, thiab tswj. Veterinary Clinics of North America: Small Animal Practice, 39(6), 1127–1158.
3. Heckeroth, AR, Menn, B., Bräu, S., & Ehret, WF (2014). Afoxolaner: Ib qho tshiab ectoparasiticide rau dev nyob rau hauv cov ntsiav tshuaj chewable formulation. Parasites & Vectors, 7(Suppl 1), O14.
4. Prichard, R., & Geary, TG (2008). Kev Tshawb Nrhiav Tshuaj: Kev cia siab tshiab rau kev tawm tsam tus dej dig muag. Xwm, 452(7189), 921–922.
5. Taenzler, J., de Vos, C., Roepke, RKA, Frénais, R., & Heckeroth, AR (2014). Kev ua tau zoo ntawm afoxolaner tiv thaiv Otodectes cynotis kab mob hauv dev. Parasites & Vectors, 7(Suppl 1), O15.
6. Wolstenholme, AJ, Fairweather, I., Prichard, R., von Samson-Himmelstjerna, G., & Sangster, NC (2004). Tshuaj tiv thaiv nyob rau hauv veterinary helminths. Trends in Parasitology, 20(10), 469–476.

